New methods to image unstable atherosclerotic plaques

Atherosclerosis. 2018 May:272:118-128. doi: 10.1016/j.atherosclerosis.2018.03.021. Epub 2018 Mar 14.

Abstract

Atherosclerotic plaque rupture is the primary mechanism responsible for myocardial infarction and stroke, the top two killers worldwide. Despite being potentially fatal, the ubiquitous prevalence of atherosclerosis amongst the middle aged and elderly renders individual events relatively rare. This makes the accurate prediction of MI and stroke challenging. Advances in imaging techniques now allow detailed assessments of plaque morphology and disease activity. Both CT and MR can identify certain unstable plaque characteristics thought to be associated with an increased risk of rupture and events. PET imaging allows the activity of distinct pathological processes associated with atherosclerosis to be measured, differentiating patients with inactive and active disease states. Hybrid integration of PET with CT or MR now allows for an accurate assessment of not only plaque burden and morphology but plaque biology too. In this review, we discuss how these advanced imaging techniques hold promise in redefining our understanding of stable and unstable coronary artery disease beyond symptomatic status, and how they may refine patient risk-prediction and the rationing of expensive novel therapies.

Keywords: Computed tomography; Positron emission tomography; Unstable plaque.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Annexin A5 / chemistry
  • Apoptosis
  • Atherosclerosis / diagnostic imaging
  • Coronary Artery Disease / diagnostic imaging
  • Diagnostic Imaging / methods*
  • Diagnostic Imaging / trends*
  • Fluorodeoxyglucose F18
  • Gallium Radioisotopes
  • Humans
  • Hypoxia
  • Inflammation
  • Ligands
  • Magnetic Resonance Imaging
  • Myocardial Infarction / diagnostic imaging
  • Neovascularization, Physiologic
  • Plaque, Atherosclerotic / diagnostic imaging*
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Risk Assessment
  • Stroke / diagnostic imaging
  • Tomography, X-Ray Computed

Substances

  • Annexin A5
  • Gallium Radioisotopes
  • Ligands
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18